Related references
Note: Only part of the references are listed.Role of NADPH Oxidases in Liver Fibrosis
Yong-Han Paik et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism
Srabani Pal et al.
JOURNAL OF INFLAMMATION-LONDON (2014)
Special issue on Oxidative stress and redox signaling in the gastrointestinal tract and related organs for Free Radical Research Involvement of free radicals and oxidative stress in NAFLD/NASH
Y. Sumida et al.
FREE RADICAL RESEARCH (2013)
Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis
Wei Wang et al.
PLOS ONE (2013)
Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease
Alexandra K. Leamy et al.
PROGRESS IN LIPID RESEARCH (2013)
Persistent fibrosis in the liver of choline-deficient and iron-supplemented L-amino acid-defined diet-induced nonalcoholic steatohepatitis rat due to continuing oxidative stress after choline supplementation
Ayano Takeuchi-Yorimoto et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease
Norberto C. Chavez-Tapia et al.
BMC GASTROENTEROLOGY (2012)
Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis
Federico Salamone et al.
TRANSLATIONAL RESEARCH (2012)
Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats
Tomokatsu Miyaki et al.
HEPATOLOGY RESEARCH (2011)
Antifibrotic Effects of Triptolide on Hepatic Stellate Cells and Dimethylnitrosamine-intoxicated Rats
Lee-Won Chong et al.
PHYTOTHERAPY RESEARCH (2011)
Insights antifibrotic mechanism of methyl palmitate: Impact on nuclear factor kappa B and proinflammatory cytokines
Eman M. Mantawy et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
Role and Cellular Source of Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Hepatic Fibrosis
Samuele De Minicis et al.
HEPATOLOGY (2010)
ROS-NFκI' mediates TGF-β1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion
Nicolas Tobar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Pathology of nonalcoholic fatty liver disease
Elizabeth M. Brunt
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats
Ming-Kuei Tsai et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells
Hella Wobser et al.
CELL RESEARCH (2009)
Deficiency of Nicotinamide Adenine Dinucleotide Phosphate, Reduced Form Oxidase Enhances Hepatocellular Injury But Attenuates Fibrosis After Chronic Carbon Tetrachloride Administration
Ghazaleh Aram et al.
HEPATOLOGY (2009)
Molecular mechanisms involved in NAFLD progression
Mariano Malaguarnera et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
Hideyuki Hyogo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats
Anita Gianella et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells
Yasushi Mukai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
NF-κB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages
Shanjin Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Pravastatin prevents myocardium from ischemia-induced fibrosis by protecting vascular endothelial cells exposed to oxidative stress
Yuichi Abe et al.
CARDIOVASCULAR DRUGS AND THERAPY (2006)
NADPH oxidase in the liver: Defensive, offensive, or fibrogenic?
Samuele De Minicis et al.
GASTROENTEROLOGY (2006)
A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients
E. Gomez-Dominguez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats
Lee-Won Chong et al.
JOURNAL OF BIOMEDICAL SCIENCE (2006)
In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells
YL Lin et al.
JOURNAL OF ETHNOPHARMACOLOGY (2006)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Fluvastatin reduces renal fibroblast proliferation and production of type III collagen: Therapeutic implications for tubulointerstitial fibrosis
H Ikeuchi et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2004)
Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar-/-) mice
T Egawa et al.
LIPIDS (2003)
Rodent nutritional model of non-alcoholic steatohepatitis: Species, strain and sex difference studies
R Kirsch et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Atorvastatin treatment induced peroxisome proliferator-activated receptor α expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats
N Roglans et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
